CATEGORIES

Pharmaceutics

LATEST

TRENDING

EDITORS CHOICE

Reblozyl (luspatercept) Approved for Treatment of Transfusion-Dependent Anemia

European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

Why We Should Be Cautious With COVID-19 Medical Research

Thalidomide’s history is a grim reminder of what can go wrong when a drug comes to market without proper clinical trials and oversight.

Drugs are Rapidly Becoming Healthcare’s Greatest Burden

Drugs have become our fallback for almost everything. Practitioners in general are massively guilty of doling them out as a panacea for socially compromised adults. Adults that possess no life skills or coping mechanisms are simply drugged into oblivion.

New Alzheimer’s Drugs Will Worsen Inequality

Disclosure: I own a fraction of a share of Eli Lilly stock. We live in a very exciting time! Alzheimer’s medications that are more promising...